Skip to content

About Matthew Martz

Professional Profile

With 22 years of engineering experience and 18+ years building and leading production AI/ML platforms and organizations, I bring proven executive leadership directing globally distributed teams of 25+ members including senior management across 10 countries. My expertise centers on building high-performing data science organizations from zero to scale, delivering measurable business value through 100x growth achievements and multi-million dollar programs spanning startups, Fortune 500 companies, and international corporations. I excel at the intersection of technical innovation, organizational development, and strategic business outcomes—transforming cutting-edge AI into production systems that drive revenue, profitability, and competitive advantage.

Current Role & Innovation Focus

As Director of AI Engineering at Gifthealth, I'm leading the development and scaling of AI foundations, capabilities, and engineering at a PE-backed digital pharmacy platform serving millions of patients nationwide. Building a graph-first, agent-native AI stack across pharmacy operations, customer experience, and healthcare workflows in a HIPAA-regulated environment — from deep agentic systems with guardrail mechanisms to Neo4j-powered knowledge graph backends integrating EHR, provider, and drug data.

My flagship innovation, AdaptQ (Activation-Driven Adaptive Pathway Tuning with Quantization), eliminates catastrophic forgetting in LLM fine-tuning—addressing the fundamental barrier preventing AI deployment in high-divergence domains (finance, medicine, legal, scientific research) representing $180B+ in market opportunity.

I lead teams advancing proprietary capabilities spanning parameter-efficient fine-tuning, knowledge graphs with GraphRAG, multimodal AI platforms, agentic systems, and federated learning—delivering production systems across consumer AI, biotechnology, agriculture, and healthcare with proven 100x growth, $M+ revenue, and 98%+ accuracy at scale.

Academic Background

My background is in Quantitative Cell Biology and I have a PhD in Biochemistry and Molecular Biology. I spent early years of my career researching novel cancer therapeutics through live cell imaging and machine learning. This foundation in rigorous scientific methodology evolved into building production AI systems—from billion-parameter recommendation engines scaling to millions of users, to knowledge graphs and digital twins modeling complex biological and business systems, to leading globally distributed teams that transform cutting-edge research into platforms delivering measurable business value across industries.

Vision: AI Platforms That Model Complex Systems at Scale

My collective experience in advanced AI, sophisticated knowledge graph development, and multimodal modeling is strategically directed towards a pioneering vision: building AI platforms that model complex systems at scale—enabling organizations to predict, optimize, and transform outcomes across consumer AI, biotechnology, agriculture, and healthcare.

These platforms leverage digital twin technology—dynamic, continuously evolving representations integrating diverse data streams to provide holistic understanding and real-time optimization. From billion-parameter consumer personalization systems to genomic discovery engines to patient digital twins, this approach represents the convergence of multimodal AI89, knowledge graphs, and production-first implementation science.

My unique strength lies at the intersection of deep innovation and pragmatic execution: I accelerate the research-to-value timeline, driving rapid translation of theoretical breakthroughs into operational systems that unlock new value channels. The ultimate aim is to profoundly impact both business outcomes and scientific advancement: delivering 100x user growth, $M+ revenue, 98%+ prediction accuracy in production systems serving millions daily, while simultaneously advancing precision medicine7, biological discovery, and agricultural innovation. This vision encompasses proven success across industries—from clinical trial design11 and treatment optimization12 to consumer recommendation engines and genomic prediction platforms.

Core Specializations

AI & Machine Learning

Multimodal AI

Foundation Models Fine-tuning Computer Vision NLP Generative AI

Knowledge Systems

Knowledge Graphs GraphRAG Agentic AI Analytical AI LLMs

Clinical Applications

Predictive Assessment Therapeutic Planning Risk Identification Digital Twins Cognitive Load Analysis

Technical Leadership

MLOps DevOps API Development Cloud Architecture Data Governance

Domain Expertise

  • Precision Medicine - 18+ years in healthcare and biomedical applications
  • Biotechnology - Genomics, omics data, and biological discovery
  • Digital Health - Clinical AI implementation and patient outcomes
  • Quantitative Biology - Live cell imaging and molecular therapeutics

Innovation Track Record

  • 5 Patents awarded or in final status for novel ML/AI applications in recommendation systems, wine chemistry optimization, and business intelligence
  • Multiple Publications in high-impact peer-reviewed journals including work on quantitative cell biology, cancer therapeutics, and machine learning applications in biomedical research
  • 100x User Growth achieved through AI-driven personalization, scaling customer base from thousands to hundreds of thousands while maintaining >95% satisfaction scores
  • $M+ Revenue Impact from predictive modeling platforms, with documented improvements in customer lifetime value (+40%), retention rates (+25%), and operational efficiency (+35%)
  • 98%+ Prediction Accuracy in production ML systems serving millions of recommendations daily with sub-100ms latency
  • 2.3M+ Patient Knowledge Graph demonstrating scalability of healthcare AI platform with 400M+ relationships
  • 15+ Clinical Interfaces and 100+ service methods developed for healthcare workflow integration
  • High-profile Media Interviews as subject matter expert in AI and Data Science for solving problems in novel domain spaces, including industry publications and conference keynotes

Leadership Philosophy

I believe in building high-performing organizations that transform AI innovation into measurable business value through:

  1. Strategic Execution - Translating ambitious technical visions into executable roadmaps with clear business outcomes
  2. Organization Building - Growing diverse, globally distributed teams from zero to scale with full P&L responsibility
  3. Production-First Culture - Ensuring innovation translates into production systems that deliver revenue and competitive advantage
  4. Cross-Functional Leadership - Navigating technical innovation, business strategy, and organizational development simultaneously
  5. Outcome-Driven Innovation - Fostering team excellence that delivers measurable impact: 100x growth, $M+ programs, and proven ROI

Connect & Collaborate

Let's Discuss

I am passionate about transforming cutting-edge AI research into production systems that deliver measurable business impact. I would love to discuss executive AI/ML leadership, strategic innovation opportunities, and how we can accelerate the research-to-value timeline to unlock new value channels across industries.

Areas for Discussion: - Executive AI/ML strategy and organizational development - Production AI platforms across consumer, biotech, agriculture, and healthcare - Knowledge graph architectures and digital twin systems - Building and scaling globally distributed AI/ML teams - Novel innovation development and IP strategy - Research-to-production acceleration and competitive advantage

Ready to transform AI innovation into business impact? Let's connect and explore how we can accelerate the research-to-value timeline, unlock new value channels, and build the next generation of AI platforms together.

Contact Information: - Email: [email protected] - LinkedIn: matthew-martz-phd - Twitter: @backpropagating - GitHub: mutaku

References

  1. Nicholson, D.N., & Greene, C.S. "Constructing knowledge graphs and their biomedical applications." Computational and Structural Biotechnology Journal, 18, 1414-1428, 2020. ↩

  2. Mohamed, S.K., et al. "Biological applications of knowledge graph embedding models." Briefings in Bioinformatics, 22(2), 1679-1693, 2021. ↩

  3. Rieke, N., et al. "The future of digital health with federated learning." NPJ Digital Medicine, 3(1), 119, 2020. ↩

  4. Li, X., et al. "Graph neural network-based diagnosis prediction." Big Data, 8(5), 379-390, 2020. ↩

  5. Institute of Medicine. "Best Care at Lower Cost: The Path to Continuously Learning Health Care in America." The National Academies Press, 2013. ↩

  6. Friedman, C.P., et al. "Toward a science of learning systems: a research agenda for the high-functioning Learning Health System." Journal of the American Medical Informatics Association, 22(1), 43-50, 2015. ↩

  7. Hamburg, M.A., & Collins, F.S. "The path to personalized medicine." New England Journal of Medicine, 363(4), 301-304, 2010. ↩

  8. Acosta, J.N., et al. "Multimodal biomedical AI." Nature Medicine, 28(9), 1773-1784, 2022. ↩

  9. Huang, S.C., et al. "Fusion of medical imaging and electronic health records using deep learning: a systematic review and meta-analysis." NPJ Digital Medicine, 3(1), 136, 2020. ↩

  10. Bauer, M.S., et al. "An introduction to implementation science for the non-specialist." BMC Psychology, 3(1), 32, 2015. ↩

  11. Venkatesh, K.P., et al. "Digital Twins for Health: Opportunities, Challenges, and Practical Implications." Nature Medicine, 28(11), 2188-2190, 2022. ↩

  12. Laubenbacher, R., et al. "Using digital twins in viral infection." Science, 371(6534), 1105-1106, 2021. ↩

  13. Corral-Acero, J., et al. "The 'Digital Twin' to enable the vision of precision cardiology." European Heart Journal, 41(48), 4556-4564, 2020.  ↩